文献速递消化系统肿瘤

非洲与欧洲血统人群结直肠癌的基因组学特征

The Genomics of Colorectal Cancer in Populations with African and European Ancestry.
PubMed 文献 · Cancer Discov · 2022-01-01

该研究对46140例结直肠腺癌进行综合基因组分析,通过祖先信息标记识别出5301例非洲血统(AFR)和33770例欧洲血统(EUR)患者。AFR患者更年轻、微卫星高度不稳定(MSI-H)肿瘤更少,KRAS、APC和PIK3CA改变显著更频繁,KRASG12D和KRASG13突变增加,但可靶向激酶驱动基因改变无差异。年轻发病结直肠癌中两种血统MSI-H/TMB-H频率相似,APC突变随年龄变化趋势显著不同。

要点

  • AFR患者KRAS(尤其KRASG12D/G13)、APC和PIK3CA改变频率高于EUR,MSI-H肿瘤频率更低。
  • 可靶向激酶驱动基因(HER2、MET、NTRK、ALK、ROS1、RET)改变频率在AFR与EUR间无差异。
  • 年轻发病(<50岁)结直肠癌中AFR与EUR的MSI-H和TMB-H频率相似,但APC突变随年龄变化趋势显著不同。

核心结论

  • AFR结直肠癌患者中KRAS(特别是KRASG12D/G13)、APC和PIK3CA改变更频繁,MSI-H肿瘤频率更低,可靶向激酶驱动基因改变无差异。
  • 年轻发病结直肠癌中AFR与EUR的MSI-H/TMB-H频率相似,但APC突变随年龄变化趋势显著不同,MAPK通路改变也存在差异。
  • 这些发现有助于治疗决策、影响预后,并强调需要代表美国多样化人群的模型系统。

研究设计与样本

  • 对46140例结直肠腺癌病例进行综合基因组分析。
  • 通过祖先信息标记识别出5301例非洲血统(AFR)患者和33770例欧洲血统(EUR)患者。

主要发现

  • AFR患者更年轻,MSI-H肿瘤更少,KRAS、APC和PIK3CA改变显著更频繁。
  • AFR患者KRAS突变频率增加,特别是KRASG12D和KRASG13。
  • 可靶向激酶驱动基因改变(HER2、MET、NTRK、ALK、ROS1、RET)频率在AFR与EUR间无差异。
  • 年轻发病(<50岁)结直肠癌中,AFR与EUR的MSI-H和TMB-H肿瘤频率相似。
  • 年轻发病结直肠癌中,AFR与EUR的APC突变随年龄变化趋势显著不同,MAPK通路改变也存在差异。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Black people have a higher incidence of colorectal cancer and worse survival rates when compared with white people. Comprehensive genomic profiling was performed in 46,140 colorectal adenocarcinoma cases. Ancestry-informative markers identified 5,301 patients of African descent (AFR) and 33,770 patients of European descent (EUR). AFR were younger, had fewer microsatellite instability-high (MSI-H) tumors, and had significantly more frequent alterations in KRAS, APC, and PIK3CA. AFR had increased frequency of KRAS mutations, specifically KRASG12D and KRASG13. There were no differences in rates of actionable kinase driver alterations (HER2, MET, NTRK, ALK, ROS1, and RET). In patients with young-onset colorectal cancer (<50 years), AFR and EUR had a similar frequency of MSI-H and tumor mutational burden-high (TMB-H) tumors, and strikingly different trends in APC mutations by age, as well as differences in MAPK pathway alterations. These findings inform treatment decisions, impact prognosis, and underscore the need for model systems representative of the diverse U.S. population. SIGNIFICANCE: KRAS (particularly KRASG12D/G13), APC, and PIK3CA were more frequently altered in AFR who had a lower frequency of MSI-H tumors. There were no differences in actionable kinase driver alterations. In young-onset colorectal cancer, both ancestries had a similar frequency of MSI-H/TMB-H tumors, but strikingly different trends in APC. See related commentary by Eng and Holowatyj, p. 1187. This article is highlighted in the In This Issue feature, p. 1171.

来源:Cancer Discov,查看原文。版权归原作者所有。

引用

  1. Myer PA, Lee JK, Madison RW, et al. The Genomics of Colorectal Cancer in Populations with African and European Ancestry. Cancer Discov. 2022. PMID: 35176763. doi:10.1158/2159-8290.CD-21-0813

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。